Open AccessEligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer
Author(s) -
Sundeep Agrawal,
Naomi B. Haas,
Mohammadhadi Bagheri,
Brian R. Lane,
Jonathan Coleman,
Hans J. Hammers,
Gennady Bratslavsky,
Cynthia Chauhan,
Lauren Kim,
Venkatesh Krishnasamy,
Jamie Marko,
V. Ellen Maher,
Amna Ibrahim,
F Richardson Cross,
Ke Liu,
Julia A. Beaver,
Richard Pazdur,
Gideon M. Blumenthal,
Harpreet Singh,
Elizabeth R. Plimack,
Toni K. Choueiri,
Robert G. Uzzo,
Andrea B. Apolo
Publication year - 2019
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2019.4117
Subject(s) - medicine , clinical trial , renal cell carcinoma , radiology , kidney cancer , nephrectomy , adjuvant therapy , cancer , kidney
To harmonize the eligibility criteria and radiologic disease assessment definitions in clinical trials of adjuvant therapy for renal cell carcinoma (RCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom